Skip to Main Content

Paper Details

Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer.
NPJ Breast Cancer
2
2023
ER, ER+/HER2- eBC, HER2, Oncologists, Oncotype, Oncotype DX, eBC, early-stage breast cancer, early-stage breast cancers, patients
Author NameAffiliation
Giuseppe CuriglianoEuropean Institute of Oncology, IRCCS
Giuseppe CuriglianoUniversity of Milan
Lajos PusztaiYale Cancer Center, Yale School of Medicine
Carmen CriscitielloEuropean Institute of Oncology, IRCCS
Carmen CriscitielloUniversity of Milan
  • 1 - 5

Datasets

Release 1.2